December 2011

Mu Sigma Closes $108M Funding

December 28, 2011

Mu Sigma, a Chicago, IL-based provider of analytics and decision support services for global enterprise customers, has closed a $108m funding. The round was led by General Atlantic, with participation from existing investor Sequoia Capital (read here), which has increased its stake. The company intends to use the funds to accelerate its growth in the [...]

Medrobotics Closes $11.7M Series C Funding

December 28, 2011

Medrobotics Corporation, a Boston, MA-based robotic snake technology developer, recently closed a $11.7m Series C funding. Backers include new angel investors and The Pittsburgh Life Sciences Greenhouse. This investment brings the total amount raised by the company to date to $28.3m. Founded by Howie Choset, Ph.D., Marco A. Zenati, M.D., and Alon Wolf, Ph.D. as [...]

Zeis Excelsa Receives €20 Investment from Fondo Italiano di Investimento

December 28, 2011

Zeis Excelsa SpA, a Montegranaro, Italy-based shoe and apparel manufacturer and supplier, has received a €20 investment from Fondo Italiano di Investimento. Fondo Italiano will acquire a minority stake in the company through a capital increase and a convertible loan. Founded in 1948 by the Pizzuti family and led by CEO Maurizio Pizzuti, Zeis manufactures [...]

Ventelo Acquired by EQT

December 28, 2011

Ventelo, a Fornebu (Oslo), Norway-based data and telecom provider, has been acquired by EQT VI for an equity value of up to NOK 1,800m. Sellers include BKK, Troms Kraft, Agder Energi, NTE, Eidsiva Bredbånd and Altibox. The investment, which is still subject to approval from the Norwegian Competition Authority, is expected to help the company [...]

Tres Amigas Recevies $12M Equity Investment from Mitsui & Co.

December 28, 2011

Tres Amigas LLC, a Santa Fe, NM, U.S.-based national grid interconnection project known as the Tres Amigas SuperStation, has recevied a $12m equity investment from global trading, IT and industrial infrastructure services company Mitsui & Co., Ltd. Mitsui will partner with Tres Amigas to further internationalize their “Smart Green Information Technology” business model, which includes Smart [...]

Grupo IMO Receives €20M Equity Investment from Nazca Capital

December 28, 2011

Grupo IMO, a Spanish provider of radiotherapy services for the treatment of cancer, has received an approximate €20m investment from Nazca Capital. Nazca, which made the investment through its Fund Nazca III, will take a majority stake in the company through the direct acquisition of shares to several shareholders as well as through the subscription [...]

MedAdherence Receives $150K in Pre-Seed Financing from Connecticut Innovations

December 27, 2011

MedAdherence LLC, a Norwalk, Conn.-based healthcare information technology company, received a $150k Pre-Seed financing from Connecticut Innovations (CI). The company, which has secured required matching funds from private investors, intends to use the funding to continue development of its technology, complete current beta testing (with Tulane University School of Medicine) and secure additional customers. Led [...]

RemoteReality Closes Series C Funding Round

December 27, 2011

RemoteReality Corporation, a Putnam, Conn.-based developer of ultra-wide-angle camera systems for military, homeland security and commercial customers, recently closed a Series C round of funding. Backers include Connecticut Innovations (CI), which committed $1m through its Eli Whitney Fund, Chart Venture Partners, Kuwait Holdings and an individual investor. Led by chairman and CEO Denny McGinn, the [...]

HzO Receives $3M Equity Investment from Horizons Ventures

December 27, 2011

HzO, a Utah-based provider of technology that protects valuable electronics from water, humidity, and other liquids, has received a $3m equity investment from Hong Kong-based Horizons Ventures, Ltd. The company, which was acquired by and then spun off from ZAGG Inc. (NASDAQ: ZAGG), intends to use the proceeds to bring its WaterBlock technology to the [...]

Provenance Biopharmaceuticals Closes $8M Financing with Alopexx Enterprises

December 27, 2011

Provenance Biopharmaceuticals Corp., a Waltham, MA-based clinical-stage biotechnology company focused on developing novel therapeutics for cancer and other serious, life-threatening diseases, has closed an $8m financing with Alopexx Enterprises, LLC. Under the terms of the transaction, the companies have formed Alopexx Oncology, LLC, which will manage the clinical development of DI-Leu16-IL2 for the treatment of [...]

← Previous Entries

Next Entries →